Organos, Inc.

Berkeley, CA · Biotech · Private

Micro-Heart Muscle (µHM) high-throughput screening platform using hiPSC-derived cardiomyocytes in polymer templates for cardiac drug discovery

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Headquarters: Berkeley, CA
Total capital: $4.8M

Federal grants: $4.8M; 6 awards · 2020–2026; Rank in peer group#13 of 42
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 6 pending · first 2023; Rank in peer group#21 of 42

Capital timeline

Latest events

Jun 2026Federal grantHealth and Human S · Phase II · Microheart muscle based discovery and development of inotropic compounds$1M
Aug 2025Federal grantHealth and Human S · Phase II · Microheart muscle based discovery and development of inotropic compounds$1M
May 2023Federal grantHealth and Human S · Phase II · High-throughput Human Micro-Heart Muscle for Drug Discovery$351K
Aug 2022Federal grantHealth and Human S · Phase II · High-throughput Human Micro-Heart Muscle for Drug Discovery$974K
Aug 2021Federal grantHealth and Human S · Phase II · Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening$537K
Sep 2020Federal grantHealth and Human S · Phase II · Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening$926K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 42 peers

Line = median

Biotech · Instrument

Federal grants#13 · top 31%
Granted patents#21 · top 50%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 7

Jul 11, 2024PendingMicrowell Array For High-throughput Screening Of Micro-tissue And Methods Of Using The SameUSPTOApplication 18570952
Dec 19, 2023GrantedMethods for Determining Drug Effects on a Mature CardiomyocyteUSPTOUS 11,846,631
Jun 22, 2023PendingDetermining Drug Effects Using Combination Of MeasurementsUSPTOApplication 17925943

Show all 7 patent records

Microwell Array For High-throughput Screening Of Micro-tissue And Methods Of Using The SameJul 11, 2024 · Application 18570952Pending
Methods for Determining Drug Effects on a Mature CardiomyocyteDec 19, 2023 · US 11,846,631Granted
Determining Drug Effects Using Combination Of MeasurementsJun 22, 2023 · Application 17925943Pending
Determining Drug Effects Using Combination Of MeasurementsApplication 63026400Pending
Microwell Array For High-throughput Screening Of Micro-tissue And Methods Of Using The SameApplication 63211645Pending
Microwell Array For High-throughput Screening Of Micro-tissue And Methods Of Using The SameApplication PCTUS2022033823Pending
Determining Drug Effects Using Combination Of MeasurementsApplication PCTUS2021032799Pending

RIDGELINE THERAPEUTICS LLCSimilar federal contract value in Biotech · null in contracts
COMPOVAX, LLCSimilar federal contract value in Biotech · null in contracts
FPRT BIO, INC.Similar federal contract value in Biotech · null in contracts
ADECTO PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
CRYOCRATE LLCSimilar federal contract value in Biotech · null in contracts
Zyversa Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.